IRIS
FRANCESCHINI, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.606
EU - Europa 5.545
AS - Asia 2.569
SA - Sud America 473
AF - Africa 144
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.539
GB - Regno Unito 1.610
CN - Cina 942
RU - Federazione Russa 885
IT - Italia 800
SG - Singapore 749
IE - Irlanda 639
UA - Ucraina 412
BR - Brasile 405
SE - Svezia 345
FR - Francia 277
DE - Germania 265
VN - Vietnam 261
HK - Hong Kong 211
FI - Finlandia 157
KR - Corea 106
ZA - Sudafrica 73
IN - India 64
BD - Bangladesh 49
TR - Turchia 48
CA - Canada 44
ES - Italia 28
BE - Belgio 27
IQ - Iraq 26
PL - Polonia 26
AR - Argentina 20
NL - Olanda 18
NG - Nigeria 16
ID - Indonesia 15
JP - Giappone 15
MX - Messico 14
CZ - Repubblica Ceca 13
SA - Arabia Saudita 13
AU - Australia 11
KE - Kenya 11
CI - Costa d'Avorio 9
CL - Cile 9
CO - Colombia 9
MY - Malesia 9
AT - Austria 8
EC - Ecuador 8
UZ - Uzbekistan 8
MA - Marocco 7
PK - Pakistan 7
EG - Egitto 6
NP - Nepal 6
VE - Venezuela 6
EU - Europa 5
JO - Giordania 5
LY - Libia 5
PY - Paraguay 5
BG - Bulgaria 4
CH - Svizzera 4
DZ - Algeria 4
IR - Iran 4
JM - Giamaica 4
KZ - Kazakistan 4
PE - Perù 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
GR - Grecia 3
HR - Croazia 3
LB - Libano 3
LV - Lettonia 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
AO - Angola 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
LK - Sri Lanka 2
LT - Lituania 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 15.352
Salva come PNG Salva come JPEG
Città #
Southend 1.511
Dallas 808
Dublin 637
Fairfield 562
Ashburn 538
Menlo Park 445
Singapore 411
Jacksonville 338
Chandler 324
Santa Clara 292
Woodbridge 258
Moscow 254
Beijing 253
San Jose 242
Houston 215
Wilmington 214
Milan 204
Hong Kong 200
Seattle 196
Cambridge 190
Ann Arbor 172
New York 140
Princeton 118
The Dalles 113
Siena 109
Seoul 106
Nanjing 104
Hefei 85
Los Angeles 84
Helsinki 80
Rome 80
Hanoi 74
Ho Chi Minh City 72
Johannesburg 65
Lauterbourg 62
Council Bluffs 55
Munich 52
Boardman 51
Nanchang 48
Dearborn 39
Buffalo 37
San Diego 37
San Mateo 35
São Paulo 33
Hebei 29
Izmir 28
Shenyang 28
Columbus 26
London 23
Orem 22
Brussels 21
San Francisco 21
Washington 21
Changsha 20
Jinan 20
Kunming 20
Shanghai 19
Toronto 19
Turku 19
Düsseldorf 18
Málaga 17
Warsaw 17
Bologna 16
Abuja 15
Bar Harbor 15
Boston 15
Frankfurt am Main 15
Jiaxing 15
Rio de Janeiro 15
Tianjin 15
Redondo Beach 14
Tokyo 14
Turin 14
Florence 13
Montreal 13
Chicago 12
Da Nang 12
Guangzhou 12
Norwalk 12
Belo Horizonte 11
Brooklyn 11
Redwood City 11
Campinas 10
Chennai 10
Dhaka 10
Dong Ket 10
Haiphong 10
Naples 10
Abidjan 9
Atlanta 9
Bengaluru 9
Brasília 9
Kraków 9
Manchester 9
Nairobi 9
Brno 8
Hangzhou 8
Poplar 8
Taizhou 8
Delhi 7
Totale 10.763
Salva come PNG Salva come JPEG
Nome #
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 353
A novel OPA1 mutation in a family with Autosomal Dominant Optic Atrophy 340
A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy. 327
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 321
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 320
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 317
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 316
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 296
Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families 286
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 278
Cavernous malformation of the optic nerve mimicking optic neuritis 270
A difficult case: sarcoidosis with CNS involvement or sarcoidosis associated with multiple sclerosis? 263
Aspetti angiografici con verde di indocianina in alcune patologie oculari 261
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 257
Uveiti Infantili : incidenza delle varie forme e correlazione con le malattie sistemiche 256
Molecular genetic study of Leber’s hereditary optic neurophaty (LHON): mutation screening by sequencing of ND1, ND4, ND%, ND6 genes 247
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 245
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 244
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 241
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 239
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 237
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 236
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 235
Optic perineuritis: A further cause of visual loss and disc edema in children 235
A new Krit1 gene mutation in a family with cerebral cavernous malformation (CCM) associated with intraorbital optic nerve and cutaneous cavernous angiomas 233
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 233
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telithromycin consumption 230
IL-6 blockade in the management of non-infectious uveitis 229
Citologia congiuntivale dei portatori di lenti a contatto morbide 220
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis 219
Pseudoistoplasmosi oculare da Candida: descrizione di un caso clinico 217
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telythromicin consumption 212
Aspetti angiografici con verde di indocianina di alcune patologie oculari 208
Atrofie ottiche " asintomatiche" della prima infanzia: difficoltà interpretative 206
Subcortical low-intensity and restricted diffusion after first seizure in a child 201
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 201
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 199
Descrizione di una nuova mutazione del gene Krit1 in una forma familiare di angioma cavernoso cerebrale associata ad angioma ottico e ad angioma cutaneo 196
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 193
Uveiti prevalentemente posteriori ed entità cliniche di incerta definizione 188
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 188
Vasculopatia occlusiva retinica in paziente con emoglobina SC 185
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 183
Irido-corneal-endothelial syndrome: a confocal and anterior segment coherent tomography differential diagnosis 179
Esoftalmo da flogosi 177
Influenza della flogosi oculare sulla concentrazione della sisomicina nell'umore acqueo di coniglio 176
Serum amyloid-A in Behçet's disease 175
Anakinra treatment in drug-resistant Behcet's disease: a case series. 172
Indicazioni e valutazione degli esami infettivologicici 165
null 165
Esame con PCR sul vitreo per la diagnosi di retinite da CMV 164
Indagini semeiologiche nelle uveiti infantili 163
Patologie dell'uvea 163
Heidelberg retina tomograph in the follow-up of papilledema 161
Successful use of canakinumab in a patient with resistant Behçet's disease 159
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 158
Patologie della sclera 156
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease 154
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis. 149
Otticopatia ischemica anteriore (O.I.A.) e lesioni ischemiche cerebrali 149
Significato del dosaggio del Retinolo e del Beta- Carotene in alcuni quadri di patologia oculare 147
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 147
Enhanced expression and function of the P2X7 purinergic receptor in peripheral blood mononuclear cells from patients with Behcet's disease 138
null 133
null 131
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 128
The pain in optic neuritis: A manifestation of visceralis hyperalgesia [Il dolore nelle neuriti ottiche: una manifestazione di iperalgesia viscerale] 125
Human Herpesvirus 6B active infection associated with recurrent bilteral optic neuritis 123
null 122
null 120
null 115
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease 114
null 113
Il dolore nelle cheratopatie e nelle lesioni dell’epitelio corneale 112
null 107
Update on the Medical Management of Gastrointestinal Behçet's Disease 93
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 85
Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection 71
Totale 15.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022957 79 120 55 72 52 13 48 30 53 108 109 218
2022/20231.272 82 115 192 166 115 266 17 91 134 24 34 36
2023/20241.020 42 16 86 39 47 361 329 13 1 15 4 67
2024/20251.906 31 95 188 106 259 111 92 110 113 74 227 500
2025/20264.579 355 659 598 471 774 166 531 138 153 231 133 370
2026/2027101 101 0 0 0 0 0 0 0 0 0 0 0
Totale 15.470